GU Cancers 2019 | A promising future for gemcitabine-oxaliplatin in cisplatin-unfit advanced urothelial carcinoma

Jae-Lyun Lee

Jae-Lyun Lee, MD, of the Asan Medical Center, Seoul, South Korea, speaks about the promising results of gemcitabine-oxaliplatin (GemOx) for advanced urothelial carcinoma (UC) to date, and discusses future directions for the treatment of cisplatin-unfit advanced UC. This video was filmed at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA.

Share this video